Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 56
Filtrar
1.
Phys Rev Lett ; 132(6): 066001, 2024 Feb 09.
Artículo en Inglés | MEDLINE | ID: mdl-38394577

RESUMEN

The normal-state conductivity and superconducting critical temperature of oxygen-deficient YBa_{2}Cu_{3}O_{7-δ} can be persistently enhanced by illumination. Strongly debated for years, the origin of those effects-termed persistent photoconductivity and photosuperconductivity (PPS)-has remained an unsolved critical problem, whose comprehension may provide key insights to harness the origin of high-temperature superconductivity itself. Here, we make essential steps toward understanding PPS. While the models proposed so far assume that it is caused by a carrier-density increase (photodoping) observed concomitantly, our experiments contradict such conventional belief: we demonstrate that it is instead linked to a photo-induced decrease of the electronic scattering rate. Furthermore, we find that the latter effect and photodoping are completely disconnected and originate from different microscopic mechanisms, since they present different wavelength and oxygen-content dependences as well as strikingly different relaxation dynamics. Besides helping disentangle photodoping, persistent photoconductivity, and PPS, our results provide new evidence for the intimate relation between critical temperature and scattering rate, a key ingredient in modern theories on high-temperature superconductivity.

2.
J Fr Ophtalmol ; 45(8S1): S24-S31, 2022 Nov.
Artículo en Francés | MEDLINE | ID: mdl-36529474

RESUMEN

Leber's hereditary optic neuropathy (LHON) is a maternally inherited disease caused by a mutation of mitochondrial DNA. LHON targets retinal ganglion cells (RGC), whose axons form the optic nerve. The mutation that leads to LHON is silent until an unknown trigger causes dysfunction of complex I in the mitochondria of RGC. This results in discontinuation of RGC energy production and, eventually, RGC apoptosis. Patients experience bilateral sequential central scotoma over the course of a few months, with a minority recovering some vision more than 1 year after the onset of visual loss. No pharmacological treatment is recommended unless patients are symptomatic in at least one eye, as most LHON mutation carriers never experience visual loss. Research has been focused on treatments that are thought to restore the mitochondrial electron transport chain in RGC in patients with recent disease onset (<1 year). Significant advances have been made in evaluating free radical cell scavengers and gene therapy as potential treatments for LHON. Although promising, the results of clinical trials have been mixed. In patients with chronic visual loss for more than 1 year, treatment that restores vision is yet to be discovered. In this review, we summarize management strategies for patients with LHON before, during, and after the loss of vision, explain the rationale and effectiveness of previous and current treatments, and report findings about emerging treatments.


Asunto(s)
Atrofia Óptica Hereditaria de Leber , Humanos , Atrofia Óptica Hereditaria de Leber/genética , Atrofia Óptica Hereditaria de Leber/terapia , Células Ganglionares de la Retina , ADN Mitocondrial/genética , Nervio Óptico , Mutación
3.
J Fr Ophtalmol ; 45(1): 1-8, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-34823891

RESUMEN

PURPOSE: In March 2020, the sudden rise in the number of SARS-CoV-2 infections in France led the government to impose a strict lockdown during which all non-urgent medical consultations were postponed. From March 17 to May 10, 2020, private medical practices were closed, and telemedicine was encouraged. The consequences on ophthalmic care were dramatic, with over 90% of scheduled consultations canceled. The goal of this study was to describe consultations during the 2-month strict lockdown in Paris and to analyze its impact on the visual outcomes of patients consulting in the ophthalmology emergency department (OED). METHODS: Data of patients who presented to the OED of the A. de Rothschild Foundation Hospital (RFH), a tertiary ophthalmology center in Paris, France, during the lockdown period and its immediate aftermath were analyzed. The results were compared to the same time periods in the years 2018 and 2019. Four time periods were defined and numbered chronologically: March 17 to May 10, 2018 (period 1); March 17 to May 10, 2019 (period 2); March 17 to May 10, 2020 (period 3, the lockdown period); May 11 to June 9, 2020 (period 4, the post-lockdown period). RESULTS: The number of consultations was reduced by more than 50% during the lockdown period (n=2909 patients) and by 30% during the post-lockdown period (n=2622) when compared to periods 1 (n=7125) and 2 (n=8058). Even though LP4 saw an increase in the number of patients consulting, there was no increase in the rate of severe diseases (12.8% during LP3 vs. 11.1% during LP4), and the proportion of patients who were admitted was statistically similar (4.3% vs. 3.6%). Neuro-ophthalmic diseases were the most common during LP3 and LP4. Neovascular glaucoma was twice as common during post-LP4 (P=0.08). We noted a significant increase in patients with graft rejection consulting in our OED during the post-LP4 (P<0.001). These results were likely related to a delay in follow-up consultations due to the lockdown measures. CONCLUSION: The reduction in the number of consultations in our OED during the lockdown period affected both minor emergencies and severe ophthalmic diseases, but with no significant delay in diagnosis. More longitudinal and longer study is needed to confirm this and to retrospectively analyze the effects of the COVID-19 outbreak and lockdown.


Asunto(s)
COVID-19 , Oftalmología , Control de Enfermedades Transmisibles , Brotes de Enfermedades , Urgencias Médicas , Humanos , Derivación y Consulta , Estudios Retrospectivos , SARS-CoV-2
4.
J Fr Ophtalmol ; 44(7): 995-1000, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34147274

RESUMEN

OBJECTIVE: Patients with autosomal optic neuropathies (AON) may develop microcystic macular degeneration (MMD), observed on retinal optical coherence tomography (OCT) examination. This study aimed to report the prevalence of MMD in AON patients and to assess the consequences of MMD on retinal architecture. METHODS: Retrospective single-center study conducted between 2001 and 2018. Patients affected by AON secondary to OPA1 or WFS1 gene mutations were included. The following data were collected: visual acuity, macular volume, vitreomacular interface and presence or absence of MMD. RESULTS: Forty-two subjects (34 OPA1, 8 WFS1) were included. MMD was found in 12 (29%) patients, i.e. 6 of the 8 WFS1 patients (75%) and 6 of the 34 OPA1 patients (17%). In cases with MMD, total retinal volume was greater (P=0.02) in accordance with thickening of the inner nuclear layer (P<0.001). WFS1 subjects had the highest total retinal volume (P=0.01), in relation to a thickening of the inner plexiform layer (P=0.02), inner nuclear layer (P<0.001) and outer plexiform layer (P=0.002). MMD was significantly associated with the WFS1 mutation (P<0.001). No significant association was found between the presence of vitreomacular adhesion and MMD. CONCLUSION: MMD was found in 29% of patients affected by AON and was more frequent in cases with a WFS1 gene mutation. MMD appears to be related to primary ganglion cell degeneration and Müller cell dysfunction. The vitreomacular interface does not appear to play a role in the occurrence of MMD.


Asunto(s)
Degeneración Macular , Enfermedades del Nervio Óptico , Estudios Transversales , Humanos , Células Ganglionares de la Retina , Estudios Retrospectivos , Tomografía de Coherencia Óptica
5.
J Bone Miner Metab ; 39(5): 725-736, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33822263

RESUMEN

INTRODUCTION: While bone literature abounds with correlations of mechanical stiffness to mineralization, such correlations are reported without relating the findings to specific intracortical locations. This study reports on mapping of stiffness and mineralization distributions in ring-shaped cortical bone samples sliced from mid-diaphyseal bovine femur. Stiffness and mineralization measurements were conducted at points across the intracortical thickness along radial lines emanating from the inner (endosteal) surface to the outer (periosteal) surface. Measurements were taken along approximately 4 mm distance of cortical bone thickness. MATERIALS AND METHODS: Three experimental techniques were employed: Vickers microhardness (HV), energy-dispersive X-ray (EDX) spectroscopy, and computed tomography (CT). Stiffness values were extracted from the Vickers microhardness tests. Elemental mineralization values (calcium %wt. and phosphorus %wt.) were determined from EDX data. All measurements were repeated on three different femur bones taken from different bovines (collected fresh from butcher). RESULTS: The study plots stiffness values and elemental mineralization (calcium %wt. and phosphorus %wt.) versus cortical thickness. Both stiffness and Ca %wt. and P %wt. are found to track and to linearly increase when plotted along the radial distance. The stiffness and mineralization trends collected from Vickers and EDX measurements were verified by employing the CT number (Hounsfield units, HU) via CT scans of the same bone samples. Data fitting via statistical methods revealed that all correlations were statistically significant. CONCLUSION: Starting from endosteal to periosteal surfaces of mid-diaphyseal bovine femur, it was found that stiffness, mineralization, and HU values all exhibit increasing and correlating trends.


Asunto(s)
Hueso Cortical , Diáfisis , Animales , Densidad Ósea , Huesos , Bovinos , Hueso Cortical/diagnóstico por imagen , Diáfisis/diagnóstico por imagen , Fémur/diagnóstico por imagen , Tomografía Computarizada por Rayos X
6.
J Fr Ophtalmol ; 44(4): 481-484, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33712335

RESUMEN

PURPOSE: To report the case of a patient with arteritic anterior ischemic optic neuropathy (AAION) with a history of glucocorticoids (GC) hypersensitivity treated with monthly intravenous tocilizumab (IV TCZ) and short course of GC. CASE REPORT: A 71-year-old Caucasian patient presented with AAION related to giant cell arteritis (GCA) confirmed by temporal artery biopsy. Past medical history was significant for GC hypersensitivity proven by allergy evaluation and the patient was managed with IV TCZ and very short-course GC. CONCLUSION: TCZ therapy with very short-course GC could be effective in GCA with ophthalmic involvement as a first-line strategy. Clinical trials are needed for thorough evaluation of the efficiency of TCZ as a first-line treatment to induce and maintain remission in patients with GCA and ocular involvement.


Asunto(s)
Arteritis de Células Gigantes , Neuropatía Óptica Isquémica , Anciano , Anticuerpos Monoclonales Humanizados , Arteritis de Células Gigantes/complicaciones , Arteritis de Células Gigantes/diagnóstico , Arteritis de Células Gigantes/tratamiento farmacológico , Glucocorticoides , Humanos , Neuropatía Óptica Isquémica/diagnóstico , Neuropatía Óptica Isquémica/tratamiento farmacológico
7.
Rev Med Interne ; 41(10): 661-666, 2020 Oct.
Artículo en Francés | MEDLINE | ID: mdl-32682624

RESUMEN

INTRODUCTION: Ocular complications of giant cell arteritis (GCA) can lead to irreversible bilateral blindness and represent a therapeutic emergency. Recommendations for the management of GCA have recently been updated. The objective of the study was to evaluate delays in appropriate management of the ocular complications of GCA and its determinants. METHOD: Retrospective, monocentric study, conducted over the period January 2013-November 2018. All consecutive patients with a final diagnosis of GCA and related visual impairment (permanent visual loss and/or alteration of visual field) were included. RESULTS: Thirty-three patients were included (women: 21, men: 12; mean age at diagnosis: 79). Twenty-seven patients (82%) presented with symptoms suggestive of ACG prior to the visual complication, ranging from a few weeks to several months. Seventeen patients (52%) had a known biological inflammatory syndrome (median CRP at 64 mg/L) prior to hospital consultation. The median time from the onset of permanent ophthalmologic manifestations to appropriate corticosteroid management was 3 days (range: 0-134). Two of the 21 patients who consulted an out-of-hospital ophthalmologist received corticosteroid therapy before referral to hospital. Three patients (9%) were treated within 24 h of the onset of the disorders. CONCLUSION: There is a significant delay in the appropriate management of ophthalmological complications of ACG and deviations from current recommendations. Numerous actions must therefore be taken to improve the visual prognosis of patients with ACG, both preventively (i.e. early diagnosis and treatment of ACG before the possible occurrence of visual complications), and curatively (rapid recognition and immediate treatment of ocular complications). These elements support the relevance of specific fast-track pathways for GCA.


Asunto(s)
Arteritis de Células Gigantes/complicaciones , Tiempo de Tratamiento/estadística & datos numéricos , Trastornos de la Visión/etiología , Trastornos de la Visión/terapia , Anciano , Anciano de 80 o más Años , Diagnóstico Tardío/estadística & datos numéricos , Femenino , Francia/epidemiología , Arteritis de Células Gigantes/epidemiología , Arteritis de Células Gigantes/terapia , Humanos , Masculino , Estudios Retrospectivos , Factores de Riesgo , Trastornos de la Visión/diagnóstico , Trastornos de la Visión/epidemiología
8.
Pulmonology ; 26(5): 291-303, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32553826

RESUMEN

BACKGROUND: Electronic (e-) cigarettes are used to heat liquids producing aerosols for inhalation. Recently there have been reports of a large number of adverse outcomes relating to e-cigarette consumption (vaping), which has been referred to as "vaping associated pulmonary illness" (VAPI). AIM: This review provides an overview of clinical, radiological and pathological features of VAPI in the literature. We also describe a case of VAPI, presenting with symptoms of bronchiolitis, responding well to azithromycin in addition to the usual treatments provided for such cases. METHODS: We searched original papers, observational studies, case reports, and meta-analyses published between 2000 and 2019 in English in PubMed database using the keywords: e-cigarette, "vaping associated pulmonary illness", VAPI, EVALI, vaping AND "lung injury". We also used data of the Centers of Disease Control (CDC) website. RESULTS: From an initial search of PubMed, 62 potential articles were identified, and another 9 studies were identified from the bibliographies of retrieved articles. In this search we found 7 case series and 16 case reports, which were included in the review. In this search we also found 4 review articles. CONCLUSION: VAPI is a syndrome presenting with isolated pulmonary or combined pulmonary, gastrointestinal and constitutional symptoms and can be rapidly progressive, leading to respiratory failure, often requiring invasive respiratory support. There is an urgent need for more research on VAPI especially relating to etiology, treatment and prevention.


Asunto(s)
Bronquiolitis/tratamiento farmacológico , Sistemas Electrónicos de Liberación de Nicotina/estadística & datos numéricos , Enfermedades Pulmonares/etiología , Vapeo/efectos adversos , Adolescente , Corticoesteroides/administración & dosificación , Corticoesteroides/uso terapéutico , Adulto , Antibacterianos/uso terapéutico , Azitromicina/uso terapéutico , Bronquiolitis/diagnóstico , Bronquiolitis/patología , Lavado Broncoalveolar/métodos , Femenino , Humanos , Enfermedades Pulmonares/diagnóstico , Enfermedades Pulmonares/epidemiología , Enfermedades Pulmonares/mortalidad , Lesión Pulmonar/complicaciones , Lesión Pulmonar/fisiopatología , Masculino , Persona de Mediana Edad , Insuficiencia Respiratoria/etiología , Insuficiencia Respiratoria/terapia , Tomografía Computarizada por Rayos X/métodos , Resultado del Tratamiento
9.
Nat Commun ; 11(1): 658, 2020 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-32005810

RESUMEN

The term tunnel electroresistance (TER) denotes a fast, non-volatile, reversible resistance switching triggered by voltage pulses in ferroelectric tunnel junctions. It is explained by subtle mechanisms connected to the voltage-induced reversal of the ferroelectric polarization. Here we demonstrate that effects functionally indistinguishable from the TER can be produced in a simpler junction scheme-a direct contact between a metal and an oxide-through a different mechanism: a reversible redox reaction that modifies the oxide's ground-state. This is shown in junctions based on a cuprate superconductor, whose ground-state is sensitive to the oxygen stoichiometry and can be tracked in operando via changes in the conductance spectra. Furthermore, we find that electrochemistry is the governing mechanism even if a ferroelectric is placed between the metal and the oxide. Finally, we extend the concept of electroresistance to the tunnelling of superconducting quasiparticles, for which the switching effects are much stronger than for normal electrons. Besides providing crucial understanding, our results provide a basis for non-volatile Josephson memory devices.

10.
Am J Ophthalmol Case Rep ; 17: 100579, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31909294

RESUMEN

PURPOSE: Nevus comedonicus is a rare developmental abnormality of the infundibulum of the hair follicle. OBSERVATION: We report here an unusual case of bilateral extensive nevus comedonicus of the eyelids complicated by bilateral ptosis and ectropion of the lower eyelids. Blepharoplasty was performed on both upper eyelids. Histopathological findings on skin biopsy typically show large, grouped, dilated follicular ostia filled with keratin. CONCLUSIONS AND IMPORTANCE: This case is unusual as regards the late-onset (lesions first appeared at age 35) and location of the nevus comedonicus on both eyelids.

12.
Poult Sci ; 98(11): 5883-5891, 2019 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-31134283

RESUMEN

Campylobacter jejuni is recognized as the most common foodborne pathogen associated with human gastroenteritis worldwide. Broilers are frequently infected by the bacteria and are considered the main source of exposure to humans. However, despite its public health impact, no recent data are currently available in Lebanon about Campylobacter spp. in poultry and human population. Therefore, this study aimed to determine the prevalence and genetic diversity of Campylobacter spp. in 227 ceca and on 227 carcasses of broiler chickens collected in Lebanese slaughterhouses. Overall, the prevalence of Campylobacter was shown to reach 67.0% in ceca and 17.2% on carcasses of Lebanese poultry. The only 2 Campylobacter species identified were C. jejuni and C. coli, with a slightly higher prevalence of C. coli in ceca and of C. jejuni on carcasses. A high level of genetic diversity was reported among the 51 C. jejuni isolates selected, since 25 distinct profiles were identified according to the comparative genomic fingerprinting typing method based on a subset of 40 genes using the 90% similarity threshold. Predominant clusters observed in Lebanese poultry isolates were also frequently found among French human clinical cases, highlighting that broiler chickens represent a potential reservoir for human campylobacteriosis. In addition, a significantly higher prevalence of Campylobacter spp. was found in slaughterhouse workers than in a cohort of hospitalized patients with no contact with poultry, confirming that contaminated broiler chickens in slaughterhouse appeared to be a non-negligible source of Campylobacter spp. transmission. Interestingly, a significant association between Campylobacter spp. and Blastocystis sp. has been observed. This correlation suggested that the presence of Campylobacter spp. would be favored when Blastocystis sp. is present and, similarly, the absence of one would favor the absence of the other. This is the first large-scale investigation focusing on the impact of Campylobacter spp. in broiler chickens in Lebanon and confirmed the need to implement prevention and control measures in the poultry production to reduce the burden of campylobacteriosis in the human population.


Asunto(s)
Infecciones por Blastocystis/veterinaria , Blastocystis/aislamiento & purificación , Infecciones por Campylobacter/veterinaria , Campylobacter/genética , Pollos , Variación Genética , Enfermedades de las Aves de Corral/epidemiología , Animales , Infecciones por Blastocystis/epidemiología , Infecciones por Blastocystis/parasitología , Campylobacter/aislamiento & purificación , Infecciones por Campylobacter/epidemiología , Infecciones por Campylobacter/microbiología , Líbano/epidemiología , Enfermedades de las Aves de Corral/microbiología , Enfermedades de las Aves de Corral/parasitología , Prevalencia
13.
J Fr Ophtalmol ; 41(7): 659-668, 2018 Sep.
Artículo en Francés | MEDLINE | ID: mdl-30173871

RESUMEN

Arboviruses are viral diseases transmitted by mosquitoes and tics bites. They are a major cause of morbidity and sometimes mortality. Their expansion is constant and due in part to climate change and globalization. Mostly found in tropical regions, arboviruses are sometimes the source of epidemics in Europe. Recently, the Chikungunya virus and the Zika virus were responsible for very large epidemics impacting populations that had never been in contact with those viruses. There are currently no effective antiviral treatments or vaccines. Ocular manifestations due to those infections are thus more frequent and increasingly better described. They are sometimes, as with Zika, complicated by a congenital ocular syndrome. The goal of this review is to describe the ophthalmological manifestations of Dengue fever, Chikungunya virus, Zika virus, West Nile virus, and yellow fever.


Asunto(s)
Infecciones por Arbovirus/diagnóstico , Enfermedades Transmisibles Emergentes/diagnóstico , Infecciones Virales del Ojo/diagnóstico , Infecciones por Arbovirus/complicaciones , Infecciones por Arbovirus/epidemiología , Arbovirus/fisiología , Fiebre Chikungunya/complicaciones , Fiebre Chikungunya/diagnóstico , Fiebre Chikungunya/epidemiología , Enfermedades Transmisibles Emergentes/complicaciones , Enfermedades Transmisibles Emergentes/epidemiología , Dengue/complicaciones , Dengue/diagnóstico , Dengue/epidemiología , Infecciones Virales del Ojo/epidemiología , Infecciones Virales del Ojo/virología , Humanos , Fiebre Amarilla/complicaciones , Fiebre Amarilla/diagnóstico , Fiebre Amarilla/epidemiología , Infección por el Virus Zika/complicaciones , Infección por el Virus Zika/diagnóstico , Infección por el Virus Zika/epidemiología
14.
J Fr Ophtalmol ; 41(6): e235-e243, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29929827

RESUMEN

Arboviruses are viral diseases transmitted by mosquitoes and tick bites. They are a major cause of morbidity and sometimes mortality. Their expansion is constant and due in part to climate change and globalization. Mostly found in tropical regions, arboviruses are sometimes the source of epidemics in Europe. Recently, the Chikungunya virus and the Zika virus were responsible for very large epidemics impacting populations that had never been in contact with those viruses. There are currently no effective antiviral treatments or vaccines. Ocular manifestations due to those infections are thus more frequent and increasingly better described. They are sometimes, as with Zika, complicated by a congenital ocular syndrome. The goal of this review is to describe the ophthalmological manifestations of Dengue fever, Chikungunya virus, Zika virus, West Nile virus, and yellow fever.


Asunto(s)
Infecciones por Arbovirus , Infecciones Virales del Ojo/epidemiología , Infecciones Virales del Ojo/virología , Infecciones por Arbovirus/diagnóstico , Infecciones por Arbovirus/epidemiología , Infecciones por Arbovirus/virología , Arbovirus/clasificación , Arbovirus/aislamiento & purificación , Fiebre Chikungunya/complicaciones , Fiebre Chikungunya/diagnóstico , Fiebre Chikungunya/epidemiología , Virus Chikungunya/aislamiento & purificación , Virus Chikungunya/fisiología , Enfermedades Transmisibles Emergentes/diagnóstico , Enfermedades Transmisibles Emergentes/epidemiología , Enfermedades Transmisibles Emergentes/virología , Dengue/complicaciones , Dengue/diagnóstico , Dengue/epidemiología , Infecciones Virales del Ojo/diagnóstico , Humanos , Virus del Nilo Occidental/aislamiento & purificación , Virus del Nilo Occidental/fisiología , Fiebre Amarilla/complicaciones , Fiebre Amarilla/diagnóstico , Fiebre Amarilla/epidemiología , Virus Zika/aislamiento & purificación , Virus Zika/fisiología , Infección por el Virus Zika/complicaciones , Infección por el Virus Zika/diagnóstico , Infección por el Virus Zika/epidemiología
16.
Rev Panam Salud Publica ; 39(4): 194-9, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27657184

RESUMEN

Objective To assess cervical cancer prevalence and associated mortality in Grenada, West Indies during 2000-2010. Methods Records of visits to hospital and clinical facilities were obtained from the histopathology laboratory of the Grenada General Hospital. Records were de-identified and electronically compiled. Cervical cancer prevalence was assessed via cross-sectional analysis of this secondary data. Of a total 12 012 records, 2 527 were selected for analysis using sampling without replacement. Cases were matched to corresponding patient data from death registries, where possible, and used to calculate associated mortality rates. Results The observed prevalence of cervical cancer was 52.4 per 100 000 women (ages 15 and above). The highest rates of cervical cancer occurred in the 35-44 age group, with the second highest among 45-64-year-olds. A total of 65 deaths were attributable to cervical cancer during 2000-2010, more than 50% of which were among women > 65 years old. The observed mortality rate was 16.7 per 100 000, almost twice the rate estimated by WHO for the region. Conclusions This study demonstrates the need for a comprehensive cervical cancer-screening program in Grenada. Results should contribute to informing future studies on how to appropriately generate and execute public health policy for education, screening, prevention, and control of cervical cancer in Grenada.


Asunto(s)
Neoplasias del Cuello Uterino/epidemiología , Adolescente , Adulto , Distribución por Edad , Anciano , Estudios Transversales , Femenino , Grenada/epidemiología , Humanos , Persona de Mediana Edad , Prevalencia , Sistema de Registros , Neoplasias del Cuello Uterino/mortalidad
17.
Rev. panam. salud pública ; 39(4): 194-199, Apr. 2016. tab, graf
Artículo en Inglés | LILACS | ID: lil-795355

RESUMEN

ABSTRACT Objective To assess cervical cancer prevalence and associated mortality in Grenada, West Indies during 2000–2010. Methods Records of visits to hospital and clinical facilities were obtained from the histopathology laboratory of the Grenada General Hospital. Records were de-identified and electronically compiled. Cervical cancer prevalence was assessed via cross-sectional analysis of this secondary data. Of a total 12 012 records, 2 527 were selected for analysis using sampling without replacement. Cases were matched to corresponding patient data from death registries, where possible, and used to calculate associated mortality rates. Results The observed prevalence of cervical cancer was 52.4 per 100 000 women (ages 15 and above). The highest rates of cervical cancer occurred in the 35–44 age group, with the second highest among 45–64-year-olds. A total of 65 deaths were attributable to cervical cancer during 2000–2010, more than 50% of which were among women > 65 years old. The observed mortality rate was 16.7 per 100 000, almost twice the rate estimated by WHO for the region. Conclusions This study demonstrates the need for a comprehensive cervical cancer-screening program in Grenada. Results should contribute to informing future studies on how to appropriately generate and execute public health policy for education, screening, prevention, and control of cervical cancer in Grenada.


RESUMEN Objetivo Evaluar la prevalencia del cáncer cervicouterino y la mortalidad asociada en Granada, Antillas Menores, entre el 2000 y el 2010. Métodos Se obtuvieron los registros de las visitas al hospital y a consultorios clínicos a partir del laboratorio de histopatología del Hospital General de Granada. Se borraron los datos personales de los registros y se los compiló electrónicamente. La prevalencia de cáncer cervicouterino se evaluó por medio del análisis transversal de estos datos secundarios. De un total de 12 012 registros, fueron seleccionados para el análisis 2 527 mediante un método de muestreo sin reemplazo. Los casos se compararon con los datos correspondientes de pacientes en los registros de defunciones, cuando fue posible, y se usaron para calcular las tasas de mortalidad asociadas. Resultados La prevalencia observada de cáncer cervicouterino fue 52,4 por 100 000 mujeres (de 15 años o más). Las tasas más elevadas de cáncer cervicouterino se observaron en el grupo de edad de 35 a 44 años, seguido por el grupo de 45 a 64 años. Del 2000 al 2010, 65 defunciones fueron atribuibles al cáncer cervicouterino, más del 50% en mujeres mayores de 65 años. La tasa de mortalidad observada fue 16,7 por 100 000, casi el doble de la calculada por la Organización Mundial de la Salud para la región. Conclusiones Este estudio indica la necesidad de establecer un programa integral de detección del cáncer cervicouterino en Granada. Los resultados deben servir como base para estudios futuros sobre cómo generar y ejecutar apropiadamente políticas de salud pública para la educación en la materia, la detección, la prevención y el control del cáncer cervicouterino en Granada.


Asunto(s)
Enfermedades del Cuello del Útero/prevención & control , Salud de la Mujer , Infecciones por Papillomavirus/complicaciones
18.
Rev Epidemiol Sante Publique ; 63(4): 259-65, 2015 Aug.
Artículo en Francés | MEDLINE | ID: mdl-26143089

RESUMEN

AIMS: Our study aimed to observe the rate of eating disorders in first year public health students (allied medical and sports) of the University of the Littoral Opal Coast (ULCO) using the SCOFF-F (Sick, Control, One, stone, Fat, Food; French version) questionnaire and to compare morphological characteristics, level of physical condition, level of physical activity and sleep quality. METHODS: Overall 642 subjects (459 women and 183 men) aged 22years (20.9±4.9years) participated in this study (Universanté-CEMHaVi). Weight, height, and fat mass were measured, and waist-to-hip ratio and body mass index (BMI) were calculated. The level of physical condition was evaluated using several physical tests: Leger and Boucher (20m) and shuttle run (4×10m), Sargent-test and handgrip strength. The SCOFF-F questionnaire followed by a clinical maintenance conducted by a professional was used to detect eating disorders. Several other questionnaires were used to evaluate the physical activity level; General Practice Assessment Questionnaire (GPAQ) and wellness. Sleep quality index was evaluated using Pittsburgh Sleep Quality Index (PSQI). RESULTS: SCOFF-F was positive in 24.2% of women and 10.2% of men. In women, there were no significant differences between those who had a positive SCOFF-F screening and those who had a negative SCOFF-F screening regarding age, height, waist-to-hip ratio, level of physical condition measured and level of physical activity evaluated. However, significant differences were found between women who had a positive SCOFF-F screening and women who had a negative SCOFF-F screening regarding sleep quality, well-being score, BMI and fat mass. In men, significant differences were found between those who had a positive SCOFF-F screening and those who had a negative SCOFF-F screening regarding BMI and fat mass. CONCLUSION: This study suggests that in both sexes, having a positive SCOFF-F screening is associated with higher BMI. In women, the increase in BMI and the perturbations in sleep quality and well-being score may indicate bulimia nervosa. The definition of a panel of possible factors associated with eating disorders can help in screening and early detection of eating disorders.


Asunto(s)
Trastornos de Alimentación y de la Ingestión de Alimentos/epidemiología , Tamizaje Masivo/métodos , Adolescente , Adulto , Índice de Masa Corporal , Trastornos de Alimentación y de la Ingestión de Alimentos/diagnóstico , Femenino , Francia/epidemiología , Humanos , Masculino , Factores de Riesgo , Estudiantes/estadística & datos numéricos , Encuestas y Cuestionarios , Universidades , Adulto Joven
19.
In. Caribbean Public Health Agency. Caribbean Public Health Agency: 60th Annual Scientific Meeting. Kingston, The University of the West Indies. Faculty of Medical Sciences, 2015. p.[1-75]. (West Indian Medical Journal Supplement).
Monografía en Inglés | MedCarib | ID: med-17965

RESUMEN

OBJECTIVE: To assess (1) the incidence and survival rates of PC, (2) the distribution of prostatic-specific antigen (PSA) and Gleason score in Grenada. DESIGN AND METHODS: A PC hospital-based series from the only urologist in the island was assembled. Age-adjusted incidence rates, PSA levels and Gleason scores for Grenada were analyzed and compared with US-Blacks and incidence rates from “International Agency for Research on Cancer (IARC)-contributing” Caribbean registries. RESULTS: 601 new cases of PC diagnosed between 1997-2013 equate to an annual age-adjusted incidence rate of 69.3 per 100,000 in Grenada. This is similar to the Jamaica rate of 77.3, but much inferior to those of US-Blacks 197.7 and Martinique 177.8. The median PSA level in Grenada was 18.0 ng/ml compared to 7.0 among US-Blacks (P<0.05). 47% of Grenadians with PC were in the high risk PSA category (>20ng/ml), compared to only 17% US-Blacks. Lower tract urinary infection and positive digital rectal examination were both significantly associated with high risk PSA and high risk Gleason score (Gleason sum ≥ 8). CONCLUSION: The lower PC incidence in Grenada and Jamaica is likely a reflection of lower prevalence of PSA-testing. Thus, PSA levels fall more substantially in the high risk category.


Asunto(s)
Próstata , Neoplasias de la Próstata , Incidencia , Tasa de Supervivencia , Antígeno Prostático Específico , Grenada
20.
In. Caribbean Public Health Agency. Caribbean Public Health Agency: 60th Annual Scientific Meeting. Kingston, The University of the West Indies. Faculty of Medical Sciences, 2015. p.[1-75]. (West Indian Medical Journal Supplement).
Monografía en Inglés | MedCarib | ID: med-18028

RESUMEN

OBJECTIVE: To study the epidemiology of OPC and assess the impact of age, stage at diagnosis, gender and treatment outside of Grenada on OPC survival. DESIGN AND METHODS: An OPC population-based series from the only ENT surgeon in the island was assembled. Age-adjusted incidence rates, and stage distribution were analyzed and compared with US-Blacks and incidence rates from regional registries. RESULTS: 93 cases of OPC diagnosed during 1991-2010 resulted in an annual age-adjusted incidence rate of 9.5 per 100,000 in Grenadian males and 1.7 among females. Jamaica’s rates were 5.2 and 2.3; Martinique’s 13.1 and 1.6; US-Blacks 15.1 and 5.0 respectively. The median age in Grenada was 58 years of age. In Grenada 73% of the cases presented with stage III/IV compared to 72% among US Blacks. Nearly 24% of patients had treatment outside of Grenada. CONCLUSION: OPC rates in Grenada were comparable to others in the region, attesting to the population basis of this series. Grenadian males show medium risk for OPC while the risk is low among females. Surprisingly, the tumor, node and metastasis (TNM) stage distribution in Grenada does not differ significantly from that among US Blacks for OPC, a cancer for which screening is rarely performed or possible.


Asunto(s)
Incidencia , Tasa de Supervivencia , Neoplasias de la Boca/epidemiología , Neoplasias Faríngeas/epidemiología , Grenada
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA